Predictive tests and early treatment delay progression of blood cell cancer

Friday, November 7, 2008 - 09:49 in Health & Medicine

Mayo Clinic researchers say they have moved closer to their goal of providing personalised care for a common blood cell cancer. They have found that the use of predictive biomarkers along with two targeted treatments significantly delays the need for conventional chemotherapy in patients with early-stage, but high-risk, chronic lymphoid leukaemia...

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net